Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Robust research: Institutions must do their part for reproducibility.
Begley CG, Buchan AM, Dirnagl U.
Nature. 2015 Sep 3;525(7567):25-7. doi: 10.1038/525025a. No abstract available.
Similar articles
A tribute to Donald Metcalf.
Begley CG.
Stem Cells. 2015 May;33(5):1683-4. doi: 10.1002/stem.2014. No abstract available.
Eliminating hepatitis B by antagonizing cellular inhibitors of apoptosis.
Ebert G, Allison C, Preston S, Cooney J, Toe JG, Stutz MD, Ojaimi S, Baschuk N, Nachbur U, Torresi J, Silke J, Begley CG, Pellegrini M.
Proc Natl Acad Sci U S A. 2015 May 5;112(18):5803-8. doi: 10.1073/pnas.1502400112. Epub 2015 Apr 20.
Cellular inhibitor of apoptosis proteins prevent clearance of hepatitis B virus.
Ebert G, Preston S, Allison C, Cooney J, Toe JG, Stutz MD, Ojaimi S, Scott HW, Baschuk N, Nachbur U, Torresi J, Chin R, Colledge D, Li X, Warner N, Revill P, Bowden S, Silke J, Begley CG, Pellegrini M.
Proc Natl Acad Sci U S A. 2015 May 5;112(18):5797-802. doi: 10.1073/pnas.1502390112. Epub 2015 Apr 20.
Functional EpoR pathway utilization is not detected in primary tumor cells isolated from human breast, non-small cell lung, colorectal, and ovarian tumor tissues.
Patterson SD, Rossi JM, Paweletz KL, Fitzpatrick VD, Begley CG, Busse L, Elliott S, McCaffery I.
PLoS One. 2015 Mar 25;10(3):e0122149. doi: 10.1371/journal.pone.0122149. eCollection 2015.
Reproducibility in science: improving the standard for basic and preclinical research.
Begley CG, Ioannidis JP.
Circ Res. 2015 Jan 2;116(1):116-26. doi: 10.1161/CIRCRESAHA.114.303819. Review.
A fully human anti-hepcidin antibody modulates iron metabolism in both mice and nonhuman primates.
Cooke KS, Hinkle B, Salimi-Moosavi H, Foltz I, King C, Rathanaswami P, Winters A, Steavenson S, Begley CG, Molineux G, Sasu BJ.
Blood. 2013 Oct 24;122(17):3054-61. doi: 10.1182/blood-2013-06-505792. Epub 2013 Aug 14.
The test of time and editorial responsibility.
Pigment Cell Melanoma Res. 2013 Sep;26(5):603-4. doi: 10.1111/pcmr.12143. Epub 2013 Jul 30. No abstract available.
An unappreciated challenge to oncology drug discovery: pitfalls in preclinical research.
Am Soc Clin Oncol Educ Book. 2013:466-8. doi: 10.1200/EdBook_AM.2013.33.466. Review.
Six red flags for suspect work.
Nature. 2013 May 23;497(7450):433-4. doi: 10.1038/497433a. No abstract available.
Drug development: Raise standards for preclinical cancer research.
Begley CG, Ellis LM.
Nature. 2012 Mar 28;483(7391):531-3. doi: 10.1038/483531a. No abstract available.
Lack of expression and function of erythropoietin receptors in the kidney.
Elliott S, Busse L, Swift S, McCaffery I, Rossi J, Kassner P, Begley CG.
Nephrol Dial Transplant. 2012 Jul;27(7):2733-45. doi: 10.1093/ndt/gfr698. Epub 2011 Dec 13.
Erythropoietin receptor in ovarian cancer cells - Letter.
Swift SE, Elliott S, Sinclair AM, Begley CG.
Mol Cancer Ther. 2010 Apr;9(4):1070-1; author reply 1071. doi: 10.1158/1535-7163.MCT-09-0439. Epub 2010 Apr 6. No abstract available.
Absence of functional EpoR expression in human tumor cell lines.
Swift S, Ellison AR, Kassner P, McCaffery I, Rossi J, Sinclair AM, Begley CG, Elliott S.
Blood. 2010 May 27;115(21):4254-63. doi: 10.1182/blood-2009-10-248674. Epub 2010 Feb 2.
Functional erythropoietin receptor is undetectable in endothelial, cardiac, neuronal, and renal cells.
Sinclair AM, Coxon A, McCaffery I, Kaufman S, Paweletz K, Liu L, Busse L, Swift S, Elliott S, Begley CG.
Blood. 2010 May 27;115(21):4264-72. doi: 10.1182/blood-2009-10-248666. Epub 2010 Feb 2.
Antihepcidin antibody treatment modulates iron metabolism and is effective in a mouse model of inflammation-induced anemia.
Sasu BJ, Cooke KS, Arvedson TL, Plewa C, Ellison AR, Sheng J, Winters A, Juan T, Li H, Begley CG, Molineux G.
Blood. 2010 Apr 29;115(17):3616-24. doi: 10.1182/blood-2009-09-245977. Epub 2010 Jan 6.
Identification of a sensitive anti-erythropoietin receptor monoclonal antibody allows detection of low levels of EpoR in cells.
Elliott S, Busse L, McCaffery I, Rossi J, Sinclair A, Spahr C, Swift S, Begley CG.
J Immunol Methods. 2010 Jan 31;352(1-2):126-39. doi: 10.1016/j.jim.2009.10.006. Epub 2009 Nov 1.
NOTCH1 pathway activation is an early hallmark of SCL T leukemogenesis.
Göthert JR, Brake RL, Smeets M, Dührsen U, Begley CG, Izon DJ.
Blood. 2007 Nov 15;110(10):3753-62. Epub 2007 Aug 13.
Macrophage-colony stimulating factor is required for the production of neutrophil-promoting activity by mouse embryo fibroblasts deficient in G-CSF and GM-CSF.
Zhang HH, Basu S, Wu F, Begley CG, Saris CJ, Dunn AR, Burgess AW, Walker F.
J Leukoc Biol. 2007 Oct;82(4):915-25. Epub 2007 Jul 25.
The Shc-binding site of the betac subunit of the GM-CSF/IL-3/IL-5 receptors is a negative regulator of hematopoiesis.
Ramshaw HS, Guthridge MA, Stomski FC, Barry EF, Ooms L, Mitchell CA, Begley CG, Lopez AF.
Blood. 2007 Nov 15;110(10):3582-90. Epub 2007 Jul 16.
Filters: Manage Filters